Non-Antibody Products — page 67 of 94
Non-Antibody Products
Page 67 of 94
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Boceprevir-d9 | An internal standard for the quantification of boceprevir by GC- or LC-MS,, | 500 µg | 31461-500 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Camostat-d6 (hydrochloride) | An internal standard for the quantification of camostat by GC- or LC-MS | 1 mg | 30984-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Camostat-d6 (hydrochloride) | An internal standard for the quantification of camostat by GC- or LC-MS | 500 µg | 30984-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-COV-2 BQ.1/BQ.1.1 (Omicron) Nucleocapsid Protein (His Tag) (HPLC-verified) | A DNA sequence encoding the SARS-CoV-2 (BQ.1 / BQ.1.1) N… | 100µg | 40588-V07E39 |
 SINO BIOLOGICAL, INC. |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 10 mg | 38589-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 25 mg | 38589-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 5 mg | 38589-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 14 | with the SARS-CoV-2 spike glycoprotein. | 50 mg | 38589-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P | A DNA sequence encoding the SARS-CoV-2 (2019-nCoV
| 100µg |
40589-V08H4 |
|
SINO BIOLOGICAL, INC.
More Info
|
|
| FDA-Approved Drugs Screening Library | For screening FDA-approved drugs; contains ~892 compounds as 10 mM stock s… | 25 µL | 23538-25µL |
CAYMAN CHEMICAL COMPANY |
More Info |
| FDA-Approved Drugs Screening Library | For screening FDA-approved drugs; contains ~892 compounds as 10 mM stock s… | 50 µL | 23538-50µL |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 10 mg | 11097-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 100 mg | 11097-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 25 mg | 11097-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 25-hydroxy Cholesterol | M); inhibits replication of SARS-CoV-2 in Vero cells (EC… | 5 mg | 11097-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike S1 (E154K, L452R, E484Q, D614G, P681R) Protein (His Tag) | A DNA sequence encoding the SARS-CoV-2 Spike S1 (YP_0097… | 100µg | 40591-V08H19 |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike S1(K417N, E484K, N501Y, D614G)-His Recombinant HEK293 Cell Lysate | HEK293 Cell SARS-CoV-2 Spike S1(K417N, E484K, N501Y, D61… | 300µg | 40591-V08H10L |
SINO BIOLOGICAL, INC. |
More Info |
| Covidyte™ IF670 | A fluorogenic substrate for coronavirus Mpro; ex / em = 656 / 670 nm | 100 test | 33768-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike S1 (Q52R, A67V, 69-70 deletion, 144 deletion, E484K, D614G, Q677H) Protein (His | A DNA sequence encoding the SARS-CoV-2 Spike S1 (YP_0097… | 100µg | 40591-V08H29 |
SINO BIOLOGICAL, INC. |
More Info |
| Saquinavir-d9 | An internal standard for the quantification of saquinavir by GC- or LC-MS | 1 mg | 28906-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Umifenovir-d6 (hydrochloride) | An internal standard for the quantification of arbidol by GC- or LC-MS | 1 mg | 31494-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Umifenovir-d6 (hydrochloride) | An internal standard for the quantification of arbidol by GC- or LC-MS | 5 mg | 31494-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Umifenovir-d6 (hydrochloride) | An internal standard for the quantification of arbidol by GC- or LC-MS | 500 µg | 31494-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| D-Pantethine | cells, and N protein and S protein levels in SARS-CoV-2… | 1 g | 39137-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| D-Pantethine | cells, and N protein and S protein levels in SARS-CoV-2… | 10 g | 39137-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| D-Pantethine | cells, and N protein and S protein levels in SARS-CoV-2… | 5 g | 39137-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| D-Pantethine | cells, and N protein and S protein levels in SARS-CoV-2… | 500 mg | 39137-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| FT113 | cells with SARS-CoV-2-mNG (EC50 = 17 nM) | 10 mg | 37545-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| FT113 | cells with SARS-CoV-2-mNG (EC50 = 17 nM) | 25 mg | 37545-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| FT113 | cells with SARS-CoV-2-mNG (EC50 = 17 nM) | 5 mg | 37545-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| FT113 | cells with SARS-CoV-2-mNG (EC50 = 17 nM) | 50 mg | 37545-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 (COVID-19) Kappa Variant (B.1.617, India) Spike RBD (E484Q, L452R) Recombinant Protein | SARS-CoV-2 (COVID-19) Kappa Variant (B.1.617, India) Spi… | 0.1 mg | orb1231121 |
 BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (G18S, A119S, A217S, M234I, E367Q) Protein (His) | Purity 98.00%. MW: approxiamtely 46.6 kDa | 100 ug | orb1953715 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike S1 (H49Y, YH145-146 deletion, E484K, D614G) Protein (His) | Purity 98.00%. MW: approxiamtely 76.5 kDa | 100 ug | orb1953732 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike S1 (K417N, E484K, N501Y, D614G) Protein (His), Biotinylated | Purity 98.00%. MW: approxiamtely 76.4 kDa | 20 ug | orb1953692 |
BIORBYT LTD. |
More Info |
| Bisoprolol-d7 (hemifumarate) | An internal standard for the quantification of bisoprolol by GC- or LC-MS | 1 mg | 30760-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Ceapin-A7 | production in Vero cells infected with SARS-CoV-2 at 15… | 10 mg | 36113-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Ceapin-A7 | production in Vero cells infected with SARS-CoV-2 at 15… | 25 mg | 36113-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Ceapin-A7 | production in Vero cells infected with SARS-CoV-2 at 15… | 5 mg | 36113-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Ceapin-A7 | production in Vero cells infected with SARS-CoV-2 at 15… | 50 mg | 36113-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 Spike S1 (Q52R, A67V, 69-70 deletion, 144 deletion, E484K, D614G, Q677H) HEK293 Cell | HEK293 Cell SARS-CoV-2 Spike S1 (Q52R, A67V, 69… | 300µg | 40591-V08H29L |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike S1 (E154K, L452R, E484Q, D614G, P681R) HEK293 Cell Lysate | HEK293 Cell SARS-CoV-2 Spike S1 (E154K, L452R, E484Q, D6… | 300µg | 40591-V08H19L |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike S1 NTD (T19R, T95I, G142D, 156-157 deletion, R158G) Protein (His Tag) | A DNA sequence encoding the SARS-CoV-2 Spike S1 NTD (YP_… | 100µg | 40591-V08H36 |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A, F817P, A892P, A899P, A942P, K986P, V987P | HEK293 Cell SARS-CoV-2 (2019-nCoV) Spike S1+S| 300µg |
40589-V08H4L |
|
SINO BIOLOGICAL, INC.
More Info
|
|
| SARS-CoV MPro-IN-2 | Purity 98.00%. MW: 230.22 | 100 mg, 50 mg, 5 mg | orb1744811 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike S1+S2 (L5F, T95I, D253G, S477N, E484K, D614G, A701V) Insect Cell Lysate | Baculovirus-Insect Cell SARS-CoV-2 Spike S1+S2… | 300µg | 40589-V08B21L |
SINO BIOLOGICAL, INC. |
More Info |
| Anti-Inflammatory Screening Library | For screening a variety of anti-inflammatory compounds; contains ~235 comp… | 50 µL | 31530-50µL |
CAYMAN CHEMICAL COMPANY |
More Info |
| IC8 | LNPs; immunization with SARS-CoV-2 spike glycoprotein m… | 10 mg | 37986-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| IC8 | LNPs; immunization with SARS-CoV-2 spike glycoprotein m… | 25 mg | 37986-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| IC8 | LNPs; immunization with SARS-CoV-2 spike glycoprotein m… | 5 mg | 37986-5 |
CAYMAN CHEMICAL COMPANY |
More Info |